World of DTC Marketing
FEBRUARY 18, 2022
Still, they are more likely to continue use because of complex medical conditions or a nonclinical factor such as lack of transportation” OK, so where to start…First, let’s ask a fundamental question “why are people using telehealth? 83% believed the quality of the patient-physician communication was good.
pharmaphorum
DECEMBER 1, 2022
Lack of access, strict regulations, and demanding schedules have made it extremely difficult for patients to participate in clinical trials. A 2018 NIH survey found that patients felt clinical trial participation to be inconvenient and burdensome, and nearly half (49.0%) said it disrupted their daily routine.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
OCTOBER 27, 2022
The Health Hackathon – which took place in the western city of Lviv in war-torn Ukraine – saw more than 40 teams showcase digital solutions to the challenges faced by patients and doctors, competing for recognition and promise of financial backing to take their projects to the next level. Main image source: WHO.
Impetus Digital
JANUARY 30, 2023
Medications and supplies must be handled with the utmost care, often needing to comply with strict temperature regulations and changing demands from patients and providers that vary depending on the country. Add this to infrastructure challenges like cold storage or delays, and it’s no wonder patient needs are not always put first.
Clarify Health
JANUARY 2, 2024
Leveraging Data to Improve Patient Journeys Healthcare Unbound episode recap: There’s never been more healthcare data (or access to it). Data on various aspects of patients’ journeys through the healthcare system are particularly powerful for both providers and payers. “But they have evolved over time.”
PM360
SEPTEMBER 15, 2022
The term “patient centricity” has been around for over a decade, and since its first utterance the buzzword has been praised, dissected, criticized, and everything in between. The concept has always been worthwhile, but people within and outside of the industry have wondered whether the industry was truly becoming more patient centric?
European Pharmaceutical Review
MARCH 4, 2024
Therefore, biologics identification and characterisation poses unparalleled challenges, as does their manufacturing processes and routes of administration while maintaining patient safety and clinical efficacy. Notably, LNPs facilitate the transportation of large payloads, have limited immunogenicity, and allow for scalable manufacturing.
Expert insights. Personalized for you.
247 
Let's personalize your content